You searched for "funding"
The central ENT decontamination model: a help or a hindrance?
According to NHS England, over 400,000 patients were waiting for ENT treatment in the UK in January 2022. This figure forms part of the overall 33.5% increase in the number of patients waiting for Referral to Treatment (RTT) compared to February 2020[1].
PuroPro headphones review
The PuroPro is the latest product from Puro Sound Labs, a family-run business focusing on high quality, sound limiting headphones. For this family business, it’s personal. The company founder’s son has a noise-induced hearing loss attributed to headphone use. With...The future of head and neck cancer surgery
Neil Sharma paints an exciting picture of the future of head and neck surgery with nanobots and robot augmented humans – science fiction or reality? Time will tell. ‘May you live in interesting times’ reads the old Chinese curse. The...4th Annual Inner Ear Disorders Therapeutics Summit
Terrri Gaskell, Chief Technology Officer, Rinri TherapueticsHeld in Boston, USA, this was an essential gathering that captured the growing excitement in both the biotech and clinical communities surrounding the rapid advancements in hearing loss therapies. With the potential to significantly...Audiology research: opportunities, career progression and leadership
A career in research can, at first glance, seem far removed from the clinical world of audiology but is that really the case? In this article Melanie Ferguson explains the role of translational research in bridging this gap, as well...Connected hearing healthcare: the realisation of benefit relies on successful clinical implementation
Connected hearing healthcare is the one of best tools for improving access to, as well as the overall quality, of hearing healthcare. Evelyn Davies-Venn and Danielle Glista discuss the benefits and important factors that contribute to successful implementation of this...
Choosing Wisely!
This article focuses on the prickly topic of healthcare costs and specifically on reducing spending on neuroimaging for headaches. Epidemiological studies indicate that the prevalence of lifetime headaches is 93 to 99% and accounts for 1.5% of all primary care...
